As previously reported, Allergan plc (“Allergan”) is in the process of evaluating a full range of potential strategic actions that will create value for shareholders, such as divestitures, combinations and acquisitions. The company has hired multiple financial advisors to assist in the review of these options.
April 19, 2018
· 7 min read